ANTHONY CLARK: It’s worth persevering with Renergen
The timeline may have been lengthened and the share diluted, but the company could well be a world-class enterprise in the making
30 March 2023 - 08:00
This column will, I’m sure, draw heated debate about a share that was at one time a market darling but has over the past months rapidly and unjustifiably turned into a conspiracy theorist’s dream and a market pariah.
The stock in question is alternative energy and helium counter Renergen. Some readers will recall my recommendation of the company as far back as the start of 2021 at R12, and at its peak, at the end of March 2022, at R43.90. As I write this column, the stock is trading at R20.50, down 17.3% in the year to date and 47.6% over 12 months...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.